CHM chimeric therapeutics limited

Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-40

  1. 7,795 Posts.
    lightbulb Created with Sketch. 907
    “What is the survival rate of a stem cell transplant?”

    ”If an allogeneic stem cell transplant is done during first remission, the 5-year disease-free survival rate is 30%–50%. If there has been no recurrence at 2 years after the stem cell transplant, the person has about an 80% chance of staying in complete remission for a long period of time.”
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $6.045M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $22.28K 6.311M

Buyers (Bids)

No. Vol. Price($)
78 84735861 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 86304338 23
View Market Depth
Last trade - 14.27pm 25/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.